Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Queensland Health
Covington
US Department of Justice
McKesson
Argus Health

Generated: April 22, 2019

DrugPatentWatch Database Preview

Hikma Intl Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for HIKMA INTL PHARMS, and when can generic versions of HIKMA INTL PHARMS drugs launch?

HIKMA INTL PHARMS has forty-three approved drugs.

There are five US patents protecting HIKMA INTL PHARMS drugs.

Summary for Hikma Intl Pharms
US Patents:5
Tradenames:30
Ingredients:30
NDAs:43

Drugs and US Patents for Hikma Intl Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Intl Pharms HYDROCHLOROTHIAZIDE hydrochlorothiazide TABLET;ORAL 084878-001 Approved Prior to Jan 1, 1982 AB RX No No ➤ Sign Up ➤ Sign Up
Hikma Intl Pharms GLYCOPYRROLATE glycopyrrolate TABLET;ORAL 040836-001 Mar 5, 2009 DISCN No No ➤ Sign Up ➤ Sign Up
Hikma Intl Pharms CAPTOPRIL captopril TABLET;ORAL 074505-004 Feb 13, 1996 AB RX No No ➤ Sign Up ➤ Sign Up
Hikma Intl Pharms PRIMIDONE primidone TABLET;ORAL 040667-001 Jul 27, 2006 DISCN No No ➤ Sign Up ➤ Sign Up
Hikma Intl Pharms MITIGARE colchicine CAPSULE;ORAL 204820-001 Sep 26, 2014 AB RX Yes Yes 9,789,108 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for HIKMA INTL PHARMS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Capsules 0.6 mg ➤ Subscribe 2016-06-10
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Julphar
Covington
Deloitte
Colorcon
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.